265. 脂肪萎縮症 Lipodystrophy Clinical trials / Disease details

臨床試験数 : 116 / 薬物数 : 170 - (DrugBank : 61) / 標的遺伝子数 : 26 - 標的パスウェイ数 : 97

16 trials found

diseases per page:

Showing 1 to 10 of 16 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01263717 (ClinicalTrials.gov)	December 2010	16/12/2010	Effects of Growth Hormone Releasing Hormone in HIV	Effects of Growth HormoneReleasing Hormone on Fat Redistribution, Cardiovascular Indices, and Growth ...	HIV;HIV Lipodystrophy	Drug: tesamorelin;Drug: placebo	Massachusetts General Hospital	NULL	Completed	18 Years	65 Years	All	54	N/A	United States
2	NCT00795210 (ClinicalTrials.gov)	February 2009	20/11/2008	Effects of Short-term Growth Hormone in HIV-infected Patients	Effects of Short-term Growth Hormone in HIV-infected Patients	HIV Lipodystrophy	Drug: Growth hormone;Drug: Growth Hormone Releasing Hormone	Massachusetts General Hospital	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	18 Years	60 Years	All	25	N/A	United States
3	EUCTR2007-003233-16-ES (EUCTR)	11/12/2007	22/10/2007	A multicenter, double-blind, randomized, placebo-controlled extension study assessing the efficacy a ...	A multicenter, double-blind, randomized, placebo-controlled extension study assessing the efficacy a ...	Lipodistrofia asociada a VIH.HIV-associated lipodystrophy. MedDRA version: 9.1;Level: LLT;Classifica ...	Product Name: Tesamorelin Product Code: TH9507 INN or Proposed INN: Tesamorelin Other descriptive name: ...	Theratechnologies Inc.	NULL	Not Recruiting			Female: yes Male: yes	300		United Kingdom;Belgium;France;Spain
4	EUCTR2007-003233-16-GB (EUCTR)	29/11/2007	02/08/2007	A Multicenter, Double-blind, Randomized, Placebo-Controlled Extension Study Assessing the Efficacy a ...	A Multicenter, Double-blind, Randomized, Placebo-Controlled Extension Study Assessing the Efficacy a ...	HIV-associated lipodystrophy MedDRA version: 9.1;Level: LLT;Classification code 10024608;Term: Lipod ...	Product Name: Tesamorelin Product Code: TH9507 INN or Proposed INN: Tesamorelin Other descriptive name: ...	Theratechnologies Inc.	NULL	Not Recruiting			Female: yes Male: yes	300	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France;Spain;Belgium;United Kingdom
5	EUCTR2007-003233-16-FR (EUCTR)	19/09/2007	31/07/2007	A Multicenter, Double-blind, Randomized, Placebo-Controlled Extension Study Assessing the Efficacy a ...	A Multicenter, Double-blind, Randomized, Placebo-Controlled Extension Study Assessing the Efficacy a ...	HIV-associated lipodystrophy MedDRA version: 9.1;Level: LLT;Classification code 10024608;Term: Lipod ...	Product Name: Tesamorelin Product Code: TH9507 INN or Proposed INN: Tesamorelin Other descriptive name: ...	Theratechnologies Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300		United Kingdom;Belgium;France;Spain
6	EUCTR2007-003233-16-BE (EUCTR)	05/09/2007	22/08/2007	A Multicenter, Double-blind, Randomized, Placebo-Controlled Extension Study Assessing the Efficacy a ...	A Multicenter, Double-blind, Randomized, Placebo-Controlled Extension Study Assessing the Efficacy a ...	HIV-associated lipodystrophy MedDRA version: 9.1;Level: LLT;Classification code 10024608;Term: Lipod ...	Product Name: Tesamorelin Product Code: TH9507 INN or Proposed INN: Tesamorelin Other descriptive name: ...	Theratechnologies Inc.	NULL	Not Recruiting			Female: yes Male: yes	300		United Kingdom;Belgium;France;Spain
7	NCT00608023 (ClinicalTrials.gov)	August 2007	23/1/2008	TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy	A Multicenter, Double-blind, Randomized, Placebo-controlled Extension Study Assessing the Efficacy a ...	Lipodystrophy;HIV Infections	Drug: Tesamorelin;Drug: Placebo for Tesamorelin	Theratechnologies	NULL	Completed	18 Years	65 Years	All	263	Phase 3	United States;Belgium;Canada;France;Spain;United Kingdom
8	EUCTR2006-005444-88-DE (EUCTR)	21/06/2007	14/08/2007	A Multicenter, Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy and Safety ...	A Multicenter, Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy and Safety ...	HIV-associated lipodystrophy MedDRA version: 8.1;Level: LLT;Classification code 10024608;Term: Lipod ...	Product Name: TH9507 Product Code: TH9507 Other descriptive name: [N-trans-3-Hexenoyl] Human Growth Ho ...	Theratechnologies Inc.	NULL	Not Recruiting			Female: yes Male: yes	400		United Kingdom;Germany;France;Spain
9	EUCTR2006-005444-88-GB (EUCTR)	08/05/2007	26/01/2007	A Multicenter, Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy and Safety ...	A Multicenter, Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy and Safety ...	HIV-associated lipodystrophy MedDRA version: 8.1;Level: LLT;Classification code 10024608;Term: Lipod ...	Product Name: TH9507 Product Code: TH9507 Other descriptive name: [N-trans-3-Hexenoyl] Human Growth Ho ...	Theratechnologies Inc.	NULL	Not Recruiting			Female: yes Male: yes	400	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France;Spain;Belgium;Germany;United Kingdom
10	EUCTR2006-005444-88-ES (EUCTR)	25/04/2007	03/03/2010	A Multicenter, Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy and Safety ...	A Multicenter, Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy and Safety ...	HIV-associated lipodystrophyLipodistrofia asociada al VIH MedDRA version: 8.1;Level: LLT;Classificat ...	Product Name: TH9507 Product Code: TH9507 Other descriptive name: [N-trans-3-Hexenoyl] Human Growth Ho ...	Theratechnologies Inc.	NULL	Not Recruiting			Female: yes Male: yes	400		Germany;United Kingdom;France;Spain

First Previous1 2Next Last